These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6618482)

  • 1. A hypothetic mechanism of diethylstilbestrol(DES)-induced anomalies in exposed progeny.
    Robboy SJ
    Hum Pathol; 1983 Oct; 14(10):831-3. PubMed ID: 6618482
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaginal adenosis: detection by colposcopy and iodine staining.
    Krumholz BA; Talebian F
    N Y State J Med; 1974 Aug; 74(9):1606-11. PubMed ID: 4136172
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of prenatal diethylstilbestrol exposure.
    Welch WR; Prat J; Robboy SJ; Herbst AL
    Pathol Annu; 1978; 13 Pt 1():201-16. PubMed ID: 364384
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaginal and cervical abnormalities after exposure to stilbestrol in utero.
    Herbst AL; Kurman RJ; Scully RE
    Obstet Gynecol; 1972 Sep; 40(3):287-98. PubMed ID: 5054957
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project.
    Robboy SJ; Kaufman RH; Prat J; Welch WR; Gaffey T; Scully RE; Richart R; Fenoglio CM; Virata R; Tilley BC
    Obstet Gynecol; 1979 Mar; 53(3):309-17. PubMed ID: 424102
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of intrauterine exposure to stilboestrol on the cervicovaginal epithelia.
    Murphy JF
    Ir J Med Sci; 1980 Jul; 149(7):261-5. PubMed ID: 7410040
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-stilbestrol secondary syndrome.
    Pomerance W
    Obstet Gynecol; 1973 Jul; 42(1):12-8. PubMed ID: 4720194
    [No Abstract]   [Full Text] [Related]  

  • 9. Genital tract abnormalities in female rats exposed to diethylstilbestrol in utero.
    Rothschild TC; Calhoon RE; Boylan ES
    Reprod Toxicol; 1987-1988; 1(3):193-202. PubMed ID: 2980383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of histologic and colposcopic findings in DES-exposed females.
    Welch WR; Robboy SJ; Townsend DE; Barnes AB; Scully RE; Herbst AL
    Obstet Gynecol; 1978 Oct; 52(4):457-61. PubMed ID: 714329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of diethylstilbestrol-associated genital tract lesions: Cervical ectopy and cervicovaginal hood.
    Antonioli DA; Burke L; Friedman EA
    Am J Obstet Gynecol; 1980 Aug; 137(7):847-53. PubMed ID: 7405976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DES-transplacental teratogen-and possibly also carcinogen.
    Ulfelder H
    Teratology; 1976 Feb; 13(1):101-3. PubMed ID: 1257911
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen participation in induction of cervicovaginal adenosis-like lesions in immature mice exposed prenatally to diethylstilbestrol.
    Iguchi T; Takei T; Takase M; Takasugi N
    Acta Anat (Basel); 1986; 127(2):110-4. PubMed ID: 3788451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
    Sharp GB; Cole P
    Am J Obstet Gynecol; 1990 Apr; 162(4):994-1001. PubMed ID: 2327468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign cervical and vaginal changes associated with exposure to stilbestrol in utero.
    Sandberg EC
    Am J Obstet Gynecol; 1976 Jul; 125(6):777-89. PubMed ID: 937403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The daughters of diethylstilbestrol. Lessons from an error.
    Tournaire M; Lepercq J; Epelboin S
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(1):25-7. PubMed ID: 9447342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    Int Surg; 1977 Mar; 62(3):152-5. PubMed ID: 852937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.